270.79MMarket Cap
14.56P/E TTM
Key Figures
3.320Open
3.410High
648.54KVolume
14.56P/E TTM
12.06P/E Dynamic
--Dividend TTM
0.82%Turnover Ratio
3.320Prev. Close
3.210Low
1.48MTurnover
31.60P/E Static
3.28P/B
0.00%Div Yield TTM
19.05%ROA
14.69052wk High
1.09Volume Ratio
8.55MNet Profit
79.46MShares
0.2335EPS TTM
2.19Beta
27.07%ROE
4.16052wk Low
6.02%Amplitude
63.47%Gross Margin
270.79MMarket Cap
-1.71Reward/Risk
3.01%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Niagen Bioscience Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.42.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Niagen Bioscience Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Niagen Bioscience Inc Highlights
StrengthsRisks
Niagen Bioscience Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Niagen Bioscience Inc
NAGE
6
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Niagen Bioscience Inc Info
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
Ticker SymbolNAGE
CompanyNiagen Bioscience Inc
CEOFried (Robert N)
Websitehttps://www.niagenbioscience.com/
Shareholders
FAQs
What is the current price of Niagen Bioscience Inc (NAGE)?
The current price of Niagen Bioscience Inc (NAGE) is 3.40.
What is the symbol of Niagen Bioscience Inc?
The ticker symbol of Niagen Bioscience Inc is NAGE.
What is the 52-week high of Niagen Bioscience Inc?
The 52-week high of Niagen Bioscience Inc is 14.69.
What is the 52-week low of Niagen Bioscience Inc?
The 52-week low of Niagen Bioscience Inc is 4.16.
What is the market capitalization of Niagen Bioscience Inc?
The market capitalization of Niagen Bioscience Inc is 270.15M.
Is Niagen Bioscience Inc (NAGE) currently rated as Buy, Hold, or Sell?
According to analysts, Niagen Bioscience Inc (NAGE) has an overall rating of Buy, with a price target of 12.42.
What is the Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE)?
The Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE) is 0.22.